Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2496
Clinical Features and Outcomes of Hydralazine-associated Vasculitis: A Case-Control Study
Vasculitis – ANCA-Associated Poster III- 10:30AM-12:30PM
-
Abstract Number: 2027
Clinical Features and Treatment of Retroperitoneal Fibrosis in a Referral Hospital and Literature Review
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2057
Clinical Features of Autoimmune Uveitis and Associated Factors with Reactivation Subtype Presentation from a Peruvian Multidisciplinary Reference Center
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2115
Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2051
Clinical Outcomes and Predictors of Relapse in Patients with IgG4-Related Disease Treated with Rituximab: A Real-World Experience
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 1994
Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2044
Clinical Practice Patterns, Rilonacept Appropriate Use for Recurrent Pericarditis
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 1930
Clinical Significance of Positive ENA Testing in ANA-Negative Patients: A Retrospective Analysis of Rheumatologic Diagnoses
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2407
Clinical Utility of Repeat Renal Biopsies in Lupus Nephritis: The NIH Chronicity Index at First Biopsy Predicts Future End Stage Renal Disease in a Large South Asian Cohort of SLE
SLE – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2208
Clinical, Imaging and Treatment Characteristics of Patients with Progressive Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Diseases (SARD-ILDs) in the ILD-PRO Registry
RA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2521
Clinicopathologic Associations Between Macrophage Location and Functional Profile in Giant Cell Arteritis
Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 10:30AM-12:30PM
-
Abstract Number: 1859
Clonal Relationships Between Tph and Tfh Cells in Patients with SLE and in Murine Lupus
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 2442
Clustering Algorithm as an Exploratory Analysis of Different Clinical Phenotypes in Systemic Sclerosis. Data from the PRECISESADS Study